Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Functional Th1-oriented T follicular helper cells that infiltrate human breast cancer promote effective adaptive immunity
Grégory Noël, … , Denis Larsimont, Karen Willard-Gallo
Grégory Noël, … , Denis Larsimont, Karen Willard-Gallo
Published August 19, 2021
Citation Information: J Clin Invest. 2021;131(19):e139905. https://doi.org/10.1172/JCI139905.
View: Text | PDF
Research Article Immunology Oncology Article has an altmetric score of 14

Functional Th1-oriented T follicular helper cells that infiltrate human breast cancer promote effective adaptive immunity

  • Text
  • PDF
Abstract

We previously demonstrated that tumor-infiltrating lymphocytes (TIL) in human breast cancer sometimes form organized tertiary lymphoid structures (TLS) characterized by CXCL13-producing T follicular helper (Tfh) cells. The present study found that CD4+ Tfh TIL, CD8+ TIL, and TIL-B, colocalizing in TLS, all express the CXCL13 receptor CXCR5. An ex vivo functional assay determined that only activated, functional Th1-oriented Tfh TIL (PD-1hiICOSint phenotype) provide help for immunoglobulin and IFN-γ production. A functional Tfh TIL presence signals an active TLS, characterized by humoral (immunoglobulins, Ki-67+ TIL-B in active germinal centers) and cytotoxic (GZMB+CD8+ and GZMB+CD68+ TIL plus Th1 gene expression) immune responses. Analysis of active versus inactive TLS in untreated patients revealed that the former are associated with positive clinical outcomes. TLS also contain functional T follicular regulatory (Tfr) TIL, which are characterized by a CD25+CXCR5+GARP+FOXP3+ phenotype and a demethylated FOXP3 gene. Functional Tfr inhibited functional Tfh activities via a glycoprotein A repetitions predominant (GARP)-associated TGF-β–dependent mechanism. The activity of tumor-associated TLS was dictated by the relative balance between functional Tfh TIL and functional Tfr TIL. These data provide mechanistic insight into TLS processes orchestrated by functional Th1-oriented Tfh TIL, including TIL-B and CD8+ TIL activation and immunological memory generation. Tfh TIL, regulated by functional Tfr TIL, are an expected key target of PD-1/PD-L1 blockade.

Authors

Grégory Noël, Mireille Langouo Fontsa, Soizic Garaud, Pushpamali De Silva, Alexandre de Wind, Gert G. Van den Eynden, Roberto Salgado, Anaïs Boisson, Hanne Locy, Noémie Thomas, Cinzia Solinas, Edoardo Migliori, Céline Naveaux, Hugues Duvillier, Sophie Lucas, Ligia Craciun, Kris Thielemans, Denis Larsimont, Karen Willard-Gallo

×

Total citations by year

Year: 2025 2024 2023 2022 2021 Total
Citations: 10 24 21 25 3 83
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (83)

Title and authors Publication Year
Methods for Selective Gene Expression Profiling in Single Tertiary Lymphoid Structure Using Laser Capture Microdissection.
Gutierrez-Chavez C, Knockaert S, Dieu-Nosjean MC, Goc J
Methods in molecular biology (Clifton, N.J.) 2025
Bioinformation study of immune microenvironment characteristics of disulfidptosis-related subtypes in ovarian cancer and prognostic model construction
Zhou Y, Zhang Y, Zhou Y, Gu Y, Chen Y, Wang J
Discover Oncology 2025
PD-1 suppresses human CD38+ circulating Tfr cells and regulates humoral immunity
Zhang H, Zheng H, Wang Y, Chen C, Tong Y, Xie S, Ma X, Guo L, Lu R
Journal for Immunotherapy of Cancer 2025
Exploring effects of gut microbiota on tertiary lymphoid structure formation for tumor immunotherapy
Liu Y, Li F, Wang J, Yang R
Frontiers in Immunology 2025
Current state of cancer immunity cycle: new strategies and challenges of using precision hydrogels to treat breast cancer
Zhu Y, Su Y, Guo Y, Wang X, Zhang Z, Lu Y, Yang H, Pang H
Frontiers in Immunology 2025
Development and evaluation of an ovarian cancer prognostic model based on adaptive immune-related genes
Shi H, Li L, Zhou L, Hong C
Medicine 2025
A CDKN2B-Associated Immune Prognostic Model for Predicting Immune Cell Infiltration and Prognosis in Esophageal Carcinoma
Peng X, Han J, Huang J, Zhou L, Chen X, Zhou W
Clinical and Experimental Gastroenterology 2025
Dynamics of tertiary lymphoid structures and immune cross talk in early versus advanced colorectal cancer: potential implications for immunotherapy
Chen Z, Hu B, Cai K, Gao H, Xian Z, Zhang S, Fang Z, Zhou Q, Ren D, Zou Q
Cancer Immunology, Immunotherapy : CII 2025
Molecular Biology and Functions of T Follicular Helper Cells in Cancer and Immunotherapy
Xin M, Wang A, Ji M, Wu J, Jiang B, Shi M, Song L, Xin Z
Immune Network 2025
Genomic Characteristics Related to Histology-based Immune Features in Breast Cancer
Cha YJ, O\u2019Connell CE, Calhoun BC, Felsheim BM, Fernandez-Martinez A, Fan C, Brueffer C, Larsson C, Borg Å, Saal LH, Perou CM
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2025
Distinct tumor microenvironment makes anaplastic thyroid cancer more lethal but sensitive to immunotherapy than papillary thyroid cancer
Pei-Zhen Han, Wei-Dong Ye, Peng-Cheng Yu, Li-Cheng Tan, Xiao Shi, Xu-Feng Chen, Cong He, Jia-Qian Hu, Wen-Jun Wei, Zhong-Wu Lu, Ning Qu, Yu Wang, Qing-Hai Ji, Dong-Mei Ji, Yu-Long Wang
JCI Insight 2024
Immune characteristics and clinical significance of peripheral blood lymphocytes in breast cancer.
Gao H, Ouyang D, Guan X, Xu J, Chen Q, Zeng L, Pang J, Zou Q, Qian K, Yi W
BMC Cancer 2024
The Emerging Role of Tertiary Lymphoid Structures in Breast Cancer: A Narrative Review.
Narvaez D, Nadal J, Nervo A, Costanzo MV, Paletta C, Petracci FE, Rivero S, Ostinelli A, Freile B, Enrico D, Pombo MT, Amat M, Aguirre ED, Chacon M, Waisberg F
Cancers 2024
The differentiation courses of the Tfh cells: a new perspective on autoimmune disease pathogenesis and treatment
Yang Q, Zhang F, Chen H, Hu Y, Yang N, Yang W, Wang J, Yang Y, Xu R, Xu C
Bioscience Reports 2024
Tertiary lymphoid structures in cancer: immune mechanisms and clinical implications
Wang S, Wang H, Li C, Liu B, He S, Tu C
2024
Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application
Zhang Y, Xu M, Ren Y, Ba Y, Liu S, Zuo A, Xu H, Weng S, Han X, Liu Z
Molecular Cancer 2024
Single-Cell Informatics for Tumor Microenvironment and Immunotherapy.
Tian J, Bai X, Quek C
International journal of molecular sciences 2024
Identification of cuproptosis-related miRNAs in triple-negative breast cancer and analysis of the miRNA-mRNA regulatory network.
Wang Y, Wang J, Jiang J, Zhang W, Sun L, Ge Q, Li C, Li X, Li X, Shi S
Heliyon 2024
The long and winding road to biomarkers for immunotherapy: a retrospective analysis of samples from patients with triple-negative breast cancer treated with pembrolizumab
Buisseret L, Bareche Y, Venet D, Girard E, Gombos A, Emonts P, Majjaj S, Rouas G, Serra M, Debien V, Agostinetto E, Garaud S, Willard-Gallo K, Larsimont D, Stagg J, Rothé F, Sotiriou C
ESMO Open 2024
Deciphering CD4+ T cell-mediated responses against cancer
Kirkpatrick C, Lu YC
Molecular Carcinogenesis 2024
Exploiting tertiary lymphoid structures gene signature to evaluate tumor microenvironment infiltration and immunotherapy response in colorectal cancer
Xu Z, Wang Q, Zhang Y, Li X, Wang M, Zhang Y, Pei Y, Li K, Yang M, Luo L, Wu C, Wang W
Frontiers in Oncology 2024
Coordinated inflammation and immune response transcriptional regulation in breast cancer molecular subtypes
Velazquez-Caldelas TE, Zamora-Fuentes JM, Hernandez-Lemus E
Frontiers in immunology 2024
New Emerging Chemokine Receptors: CCR5 or CXCR5 on Tumor Is Associated with Poor Response to Chemotherapy and Poor Prognosis in Locally Advanced Triple-Negative Breast Cancer
Cabioglu N, Onder S, Karatay H, Bayram A, Oner G, Tukenmez M, Muslumanoglu M, Igci A, Dinccag A, Ozmen V, Aydiner A, Saip P, Yavuz E
Cancers 2024
Mature tertiary lymphoid structures: important contributors to anti-tumor immune efficacy
Bao X, Lin X, Xie M, Yao J, Song J, Ma X, Zhang X, Zhang Y, Liu Y, Han W, Liang Y, Hu H, Xu L, Xue X
Frontiers in immunology 2024
Lymphocyte homing and recirculation with tumor tertiary lymphoid structure formation: predictions for successful cancer immunotherapy
Tian W, Wei W, Qin G, Bao X, Tong X, Zhou M, Xue Y, Zhang Y, Shao Q
Frontiers in immunology 2024
Density of tertiary lymphoid structures predicts clinical outcome in breast cancer brain metastasis
Zhao YY, Fan Z, Tao BR, Du ZG, Shi ZF
Journal for ImmunoTherapy of Cancer 2024
Tertiary lymphoid structures in anticancer immunity.
Teillaud JL, Houel A, Panouillot M, Riffard C, Dieu-Nosjean MC
Nature reviews. Cancer 2024
A Mature Tertiary Lymphoid Structure with a Ki-67-Positive Proliferating Germinal Center Is Associated with a Good Prognosis and High Intratumoral Immune Cell Infiltration in Advanced Colorectal Cancer
Mori N, Dorjkhorloo G, Shiraishi T, Erkhem-Ochir B, Okami H, Yamaguchi A, Shioi I, Komine C, Endo M, Seki T, Hosoi N, Nakazawa N, Shibasaki Y, Okada T, Osone K, Sano A, Sakai M, Sohda M, Yokobori T, Shirabe K, Saeki H
Cancers 2024
Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances
Zhao L, Jin S, Wang S, Zhang Z, Wang X, Chen Z, Wang X, Huang S, Zhang D, Wu H
Signal Transduction and Targeted Therapy 2024
Tumor-Infiltrating Lymphocyte Scoring in Neoadjuvant-Treated Breast Cancer
Thomas N, Garaud S, Langouo M, Sofronii D, Boisson A, De Wind A, Duwel V, Craciun L, Larsimont D, Awada A, Willard-Gallo K
Cancers 2024
Anoikis-related genes in breast cancer patients: reliable biomarker of prognosis.
Tang M, Rong Y, Li X, Pan H, Tao P, Wu Z, Liu S, Tang R, Liu Z, Cai H
BMC cancer 2024
CD4(+) T cells in antitumor immunity.
Montauti E, Oh DY, Fong L, Montauti E, Oh DY, Fong L
Trends in cancer 2024
Help me help you: emerging concepts in T follicular helper cell differentiation, identity, and function.
Wellford SA, Schwartzberg PL
Current opinion in immunology 2024
Global trends in tertiary lymphoid structures: a bibliometric analysis from 2014 to 2023
Bao Y, Mo Z, Wang S, Long J, Zhang H, Xu Y, Jiang H, Qian T, Zeng Z
Frontiers in Immunology 2024
Follicle-like tertiary lymphoid structures: A potential biomarker for prognosis and immunotherapy response in patients with laryngeal squamous cell carcinoma
Liang H, Zhang Z, Guan Z, Zheng S, Lou J, Liu W, Cai Q, Si Y
Frontiers in immunology 2023
Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases
Zhang C, Wang XY, Zuo JL, Wang XF, Feng XW, Zhang B, Li YT, Yi CH, Zhang P, Ma XC, Chen ZM, Ma Y, Han JH, Tao BR, Zhang R, Wang TQ, Tong L, Gu W, Wang SY, Zheng XF, Yuan WK, Kan ZJ, Fan J, Hu XY, Li J, Zhang C, Chen JH
Journal for ImmunoTherapy of Cancer 2023
Human intestinal B cells in inflammatory diseases.
Spencer J, Bemark M
Nature reviews. Gastroenterology & hepatology 2023
CD4(+) T cells in cancer.
Speiser DE, Chijioke O, Schaeuble K, Münz C
Nature cancer 2023
Immunocyte Infiltration Analysis and Immunohistochemistry Identify EVL as a Potential Prognostic Biomarker for Pancreatic Cancer
Du Y, Zhu L, Li X, Shi H, Jiang W, Zhou W
Journal of Personalized Medicine 2023
Hedgehog-induced ZFYVE21 promotes chronic vascular inflammation by activating NLRP3 inflammasomes in T cells.
Jiang B, Wang S, Song G, Jiang Q, Fan M, Fang C, Li X, Soh CL, Manes TD, Cheru N, Qin L, Ren P, Jortner B, Wang Q, Quaranta E, Yoo P, Geirsson A, Davis RP, Tellides G, Pober JS, Jane-Wit D
Science signaling 2023
B cells and tertiary lymphoid structures are associated with survival in papillary thyroid cancer.
Li YY, Li SJ, Liu MC, Chen Z, Li L, Shen F, Liu QZ, Xu B, Lian ZX
Journal of Endocrinological Investigation 2023
T peripheral helper cells in autoimmune diseases: What do we know?
Huang Y, Ba X, Han L, Wang H, Lin W, Chen Z, Tu S
Frontiers in immunology 2023
Spatial Positioning of Immune Hotspots Reflects the Interplay between B and T Cells in Lung Squamous Cell Carcinoma.
Zhang H, AbdulJabbar K, Moore DA, Akarca A, Enfield KSS, Jamal-Hanjani M, Raza SEA, Veeriah S, Salgado R, McGranahan N, Le Quesne J, Swanton C, Marafioti T, Yuan Y
Cancer research 2023
The role of tumor-infiltrating lymphocytes in triple-negative breast cancer and the research progress of adoptive cell therapy
Li R, Cao L
Frontiers in immunology 2023
Intratumoral dendritic cell-CD4(+) T helper cell niches enable CD8(+) T cell differentiation following PD-1 blockade in hepatocellular carcinoma.
Magen A, Hamon P, Fiaschi N, Soong BY, Park MD, Mattiuz R, Humblin E, Troncoso L, D'souza D, Dawson T, Kim J, Hamel S, Buckup M, Chang C, Tabachnikova A, Schwartz H, Malissen N, Lavin Y, Soares-Schanoski A, Giotti B, Hegde S, Ioannou G, Gonzalez-Kozlova E, Hennequin C, Le Berichel J, Zhao Z, Ward SC, Fiel I, Kou B, Dobosz M, Li L, Adler C, Ni M, Wei Y, Wang W, Atwal GS, Kundu K, Cygan KJ, Tsankov AM, Rahman A, Price C, Fernandez N, He J, Gupta NT, Kim-Schulze S, Gnjatic S, Kenigsberg E, Deering RP, Schwartz M, Marron TU, Thurston G, Kamphorst AO, Merad M
Nature Medicine 2023
T cells in health and disease.
Sun L, Su Y, Jiao A, Wang X, Zhang B
Signal Transduction and Targeted Therapy 2023
Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy.
Zou X, Guan C, Gao J, Shi W, Cui Y, Zhong X
Frontiers in immunology 2023
Tertiary lymphoid structures and B lymphocytes: a promising therapeutic strategy to fight cancer
Esparcia-Pinedo L, Romero-Laorden N, Alfranca A
Frontiers in immunology 2023
Integration of single-cell RNA sequencing and bulk RNA transcriptome sequencing reveals a heterogeneous immune landscape and pivotal cell subpopulations associated with colorectal cancer prognosis
Zhang Q, Liu Y, Wang X, Zhang C, Hou M, Liu Y
Frontiers in immunology 2023
Construction of stemness gene score by bulk and single-cell transcriptome to characterize the prognosis of breast cancer.
Lin J, Feng D, Liu J, Yang Y, Wei X, Lin W, Lin Q
Aging 2023
Pro-tumor Tfh2 cells induce detrimental IgG4 production and PGE2-dependent IgE inhibition in pancreatic cancer
De Monte L, Clemente F, Ruggiero E, Pini R, Ceraolo MG, Schiavo Lena M, Balestrieri C, Lazarevic D, Belfiori G, Crippa S, Balzano G, Falconi M, Doglioni C, Bonini C, Reni M, Protti MP
EBioMedicine 2023
Dual Functions of T Lymphocytes in Breast Carcinoma: From Immune Protection to Orchestrating Tumor Progression and Metastasis
Zareinejad M, Mehdipour F, Roshan-Zamir M, Faghih Z, Ghaderi A
Cancers 2023
Exploring the dual role of B cells in solid tumors: implications for head and neck squamous cell carcinoma
Bao J, Betzler AC, Hess J, Brunner C
Frontiers in immunology 2023
Bioinformatic analysis of m6A “reader” YTH family in pan-cancer as a clinical prognosis biomarker
Li L, Tang C, Ye J, Xu D, Chu C, Wang L, Zhou Q, Gan S, Liu B
Scientific Reports 2023
Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer
Wilkerson AD, Parthasarathy PB, Stabellini N, Mitchell C, Pavicic PG Jr, Fu P, Rupani A, Husic H, Rayman PA, Swaidani S, Abraham J, Budd GT, Moore H, Al-Hilli Z, Ko JS, Baar J, Chan TA, Alban T, Diaz-Montero CM, Montero AJ
Clinical cancer research 2023
Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer
C Hsieh, C Jian, L Lin, G Low, P Ou, C Hsu, D Ou
Cancers 2022
T follicular helper and B cell crosstalk in tertiary lymphoid structures and cancer immunotherapy
S Garaud, M Dieu-Nosjean, K Willard-Gallo
Nature Communications 2022
Dissecting Tumor-Immune Microenvironment in Breast Cancer at a Spatial and Multiplex Resolution
E Tzoras, I Zerdes, N Tsiknakis, G Manikis, A Mezheyeuski, J Bergh, A Matikas, T Foukakis
Cancers 2022
Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities
C Laumont, A Banville, M Gilardi, D Hollern, B Nelson
Nature Reviews Cancer 2022
Assessing Tumor-Infiltrating Lymphocytes in Breast Cancer: A Proposal for Combining Immunohistochemistry and Gene Expression Analysis to Refine Scoring
H Locy, S Verhulst, W Cools, W Waelput, S Brock, L Cras, A Schiettecatte, J Jonckheere, L van Grunsven, M Vanhoeij, K Thielemans, K Breckpot
Frontiers in immunology 2022
Targeting TFH cells in human diseases and vaccination: rationale and practice.
Yu D, Walker LSK, Liu Z, Linterman MA, Li Z
Nature Immunology 2022
Tertiary Lymphatic Structures in Primary Hepatic Carcinoma: Controversy Cannot Overshadow Hope
Jia W, Zhang T, Yao Q, Li J, Nie Y, Lei X, Mao Z, Wang Y, Shi W, Song W
Frontiers in immunology 2022
Dynamic Immune Function Changes Before and After the First Radioactive Iodine Therapy After Total Resection of Differentiated Thyroid Carcinoma
Shi ZY, Zhang SX, Fan D, Li CH, Cheng ZH, Xue Y, Wu LX, Lu KY, Yang SY, Cheng Y, Wu ZF, Gao C, Li XF, Liu HY, Li SJ
Frontiers in immunology 2022
3D Collagen Fiber Concentration Regulates Treg Cell Infiltration in Triple Negative Breast Cancer
Gao H, Tian Q, Zhou Y, Zhu L, Lu Y, Ma Y, Feng J, Jiang Y, Wang B
Frontiers in immunology 2022
The Presence of Tertiary Lymphoid Structures Provides New Insight Into the Clinicopathological Features and Prognosis of Patients With Breast Cancer.
Wang B, Liu J, Han Y, Deng Y, Li J, Jiang Y
Frontiers in immunology 2022
Workflow for high-dimensional flow cytometry analysis of T cells from tumor metastases.
Faccani C, Rotta G, Clemente F, Fedeli M, Abbati D, Manfredi F, Potenza A, Anselmo A, Pedica F, Fiorentini G, Villa C, Protti MP, Doglioni C, Aldrighetti L, Bonini C, Casorati G, Dellabona P, de Lalla C
Life science alliance 2022
Intratumoral Niches of B Cells and Follicular Helper T Cells, and the Absence of Regulatory T Cells, Associate with Longer Survival in Early-Stage Oral Tongue Cancer Patients.
Phanthunane C, Wijers R, De Herdt MJ, Koljenovicć S, Sleijfer S, Baatenburg de Jong RJ, Hardillo JAU, Debets R, Balcioglu HE
Cancers 2022
Differential distribution and prognostic value of CD4+ T cell subsets before and after radioactive iodine therapy in differentiated thyroid cancer with varied curative outcomes.
Shi ZY, Zhang SX, Li CH, Fan D, Xue Y, Cheng ZH, Wu LX, Lu KY, Wu ZF, Li XF, Liu HY, Li SJ
Frontiers in immunology 2022
Leveraging the Dynamic Immune Environment Triad in Patients with Breast Cancer: Tumour, Lymph Node, and Peripheral Blood
Wall I, Boulat V, Shah A, Blenman KR, Wu Y, Alberts E, Calado DP, Salgado R, Grigoriadis A
Cancers 2022
Immune landscape and risk prediction based on pyroptosis-related molecular subtypes in triple-negative breast cancer
Luo L, Wei Q, Xu C, Dong M, Zhao W
Frontiers in immunology 2022
The soldiers needed to be awakened: Tumor-infiltrating immune cells
Yaping W, Zhe W, Zhuling C, Ruolei L, Pengyu F, Lili G, Cheng J, Bo Z, Liuyin L, Guangdong H, Yaoling W, Niuniu H, Rui L
Frontiers in Genetics 2022
Multiplexed In Situ Spatial Protein Profiling in the Pursuit of Precision Immuno-Oncology for Patients with Breast Cancer
Massa D, Tosi A, Rosato A, Guarneri V, Dieci MV
Cancers 2022
Heterogeneity and Functions of Tumor-Infiltrating Antibody Secreting Cells: Lessons from Breast, Ovarian, and Other Solid Cancers
Lounici Y, Le Saux O, Chemin G, Wajda P, Barrin S, Berthet J, Caux C, Dubois B
Cancers 2022
Effect of Tertiary Lymphoid Structures on Prognosis of Patients with Hepatocellular Carcinoma and Preliminary Exploration of Its Formation Mechanism.
Li J, Nie Y, Jia W, Wu W, Song W, Li Y
Cancers 2022
Tertiary lymphoid structures as unique constructions associated with the organization, education, and function of tumor-infiltrating immunocytes.
Chen J, Chen J, Wang L
Journal of Zhejiang University. Science. B 2022
Identification of immune cell function in breast cancer by integrating multiple single-cell data
Zhang L, Qin Q, Xu C, Zhang N, Zhao T
Frontiers in immunology 2022
Tertiary Lymphoid Structures: A Potential Biomarker for Anti-Cancer Therapy
Zou J, Zhang Y, Zeng Y, Peng Y, Liu J, Xiao C, Wu F
Cancers 2022
Screening of the novel immune-suppressive biomarkers of TMED family and whether knockdown of TMED2/3/4/9 inhibits cell migration and invasion in breast cancer
Fang Z, Song YX, Wo GQ, Zhou HL, Li L, Yang SY, Chen X, Zhang J, Tang JH
Annals of translational medicine 2022
B cells in human lymphoid structures.
Montorsi L, Siu JHY, Spencer J
Clinical & Experimental Immunology 2022
Novel insights into Hodgkin lymphoma biology by single-cell analysis
Aoki T, Steidl C
Blood 2022
Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses
C Cui, J Wang, E Fagerberg, PM Chen, KA Connolly, M Damo, JF Cheung, T Mao, AS Askari, S Chen, B Fitzgerald, GG Foster, SC Eisenbarth, H Zhao, J Craft, NS Joshi
Cell 2021
Fluorescent Multiplex Immunohistochemistry Coupled With Other State-Of-The-Art Techniques to Systematically Characterize the Tumor Immune Microenvironment
A Boisson, G Noël, M Saiselet, J Rodrigues-Vitória, N Thomas, ML Fontsa, D Sofronii, C Naveaux, H Duvillier, L Craciun, D Larsimont, A Awada, V Detours, K Willard-Gallo, S Garaud
Frontiers in Molecular Biosciences 2021
Expression and Clinical Significance of Origin Recognition Complex Subunit 6 in Breast Cancer – A Comprehensive Bioinformatics Analysis
S Chen, Z Jin, L Xin, L Lv, X Zhang, Y Gong, J Liu
International journal of general medicine 2021

← Previous 1 2 3 4 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Blogged by 1
Posted by 11 X users
101 readers on Mendeley
See more details